Table 2.
Stereotactic fractionated photon radiotherapy: Results (n = 24)
| Radiotherapy dose in BED | ||
| Median | 78 Gy | |
| Range | 37.5–131.25 Gy | |
| Follow up | 5.2 years | |
| n | % | |
| Linear accelerator-based fractionated photon radiotherapy | ||
| Primary irradiation | 24 | 100 | 
| Re-irradiation | 2 | 8.3 | 
| Local response | ||
| Complete remission | 1 | 4.2 | 
| Partial remission | 8 | 33.3 | 
| Stable disease | 11 | 45.8 | 
| Progressive disease | 4 | 16.7 | 
| Enucleation rate | 5 | 20.9 | 
| Due to grade 4 toxicity | 4 | 16.7 | 
| Due to recurrence | 1 | 4.2 | 
| Eye conservation | 19 | 79.1 | 
| Blindness before radiotherapy (n = 24) | 4 | 16.7 | 
| Blindness after 24 months (n = 20) | ||
| Due to grade 4 toxicity | 5 | 25.0 | 
| Due to recurrence | 0 | 0 |